Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Total Debt (2022 - 2026)

Updated

Adaptin Bio (APTN) recorded Total Debt of $162,208 in Q2 2026, down 32.6% from the prior quarter.

Analysis

Adaptin Bio (APTN) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2024, Adaptin Bio reported Total Debt of $1.52 million.

  • Across earlier years, Total Debt came in at $81,219 in FY2023 and $304.00 in FY2022.
  • The Q2 2026 figure is the lowest quarterly Total Debt since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 162,208.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162,208.00
Mar 31, 2026 240,698.00
Dec 31, 2024 1.52 Mn
Sep 30, 2024 182,514.00
Jun 30, 2024 153,072.00
Mar 31, 2024 81,219.00
Dec 31, 2023 81,219.00
Sep 30, 2023 50,622.00
Dec 31, 2022 5,304.00
API Access

Adaptin Bio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=APTN&period=max&api_key=YOUR_API_KEY